PBHC
Pathfinder Bancorp Inc
17.40$
-5.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.7% | -0.8% | -0.5% | +2.6% | -0.6% | +1.4% | +0.7% | -2.2% | -3.2% | -0.2% | +4.9% | |
| – | +32.3% | +0.2% | -0.5% | +0.1% | -2.0% | +11.2% | -0.9% | +0.7% | +240.2% | -98.3% | -9.3% | |
| – | +99.1% | -40.0% | +8.9% | +11.0% | -10.6% | +63.0% | -38.8% | +28.9% | -71.6% | +20.8% | -18.1% | |
| – | +32.9% | +0.3% | -0.5% | +0.2% | -2.1% | +11.5% | -0.9% | +0.8% | -13.9% | -0.5% | +31.6% | |
| – | +10.5% | -1.6% | -1.3% | -3.8% | +1.1% | -1.9% | +2.1% | -5.7% | +13,343.6% | -99.3% | +11.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +26.8% | -12.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -3.4% | -5.9% | -5.0% | +8,080.3% | -3.7% | -2.6% | -2.7% | -2.8% | -2.8% | -2.9% | -3.0% | |
| – | +4.6% | -1.1% | -0.7% | +3.0% | -0.6% | +1.3% | +0.7% | -2.5% | -3.1% | -0.4% | +5.3% | |
| – | +5.2% | -0.7% | -0.7% | +2.1% | +0.7% | +2.1% | +0.5% | -2.6% | -96.5% | -65.7% | +728.3% | |
| – | +121.7% | -27.1% | +39.3% | -52.7% | +1.1% | -55.7% | +179.6% | -49.7% | +15.8% | -65.7% | +728.3% | |
| – | +29.7% | -12.6% | +6.6% | -88.7% | +131.4% | +54.6% | -3.7% | +39.5% | -62.6% | +6.4% | +4.0% | |
| – | -4.7% | -5.0% | +0.1% | -8.0% | -18.1% | -16.4% | +7.1% | -4.3% | -9.7% | -3.8% | -9.4% | |
| – | +5.0% | +1.9% | +1.3% | -2.5% | +1.0% | +2.8% | -0.4% | +1.5% | -4.3% | +2.2% | +1.7% | |
| – | +2.4% | +2.0% | +1.8% | -6.7% | +5.6% | +3.0% | -0.7% | 0.0% | -9.7% | +4.5% | +2.7% | |
| – | +0.5% | +0.2% | +0.1% | +0.1% | +0.4% | +0.4% | +0.2% | +0.2% | +33.1% | -1.3% | -21.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.